“Global ophthalmology PCAS market will grow at a CAGR over 5% by 2030”, says Visiongain

23 January 2020
Pharma

Visiongain’s new report the Ophthalmology PCAS Market Report 2020-2030: Forecasts by Type (stand alone and integrated), by Delivery Mode (cloud based and on premises) by End Use (Hospitals and Specialty Clinics) plus analysis of leading companies indicates that the global ophthalmology PCAS market will grow at a CAGR over 5% by 2030.

Increasing the use of teleophthalmology solutions due to the lack of professional ophthalmologists and optometrists are key drivers of market growth. Moreover, significant growth in Information Technology (IT) and its rising impact on the ophthalmology practices is anticipated to drive the market. In addition, high prevalence of diabetes and eye disease such as Diabetic Macular Edema (DME), diabetic retinopathy, cataract, and glaucoma are likely to boost the sector. For example, according to a report carried out by the International Diabetes Federation (IDF), some 3.27 million diabetes cases were diagnosed in France in 2017.

Increasing the burden of ophthalmic disease, high unmet medical needs in emerging economies, and increased spending on public and private health care to improve vision care services would fuel demand further. In addition, increased demand for early and reliable methods of detection is expected to fuel market growth in the coming years. Electronic Health Record (EHR) and Electronic Medical Record (EMR) programs provide healthcare service providers with complete and accurate information to help improve treatment and reducing medical errors. Government organizations will therefore take initiatives to encourage the adoption of EHR and EMR to further use ophthalmic PACS systems for fuel. The segment of Integrated Systems held the major share of the global market for PACS ophthalmology.

Such systems incorporate medical applications such as integration of data, functional integration, context integration, and integration of presentation. The diagnostic tool systems thus provide physicians with the ability to monitor medical records and test tests from anywhere and at any time. Advances in the segment's technology and service will further boost growth in the near future. Heidelberg Engineering, for example, unveiled SPECTRALIS glaucoma and retina imaging system in November 2015.

Features provided by integrated systems such as ease of understanding, good user interface, data portability, protection, cost-effectiveness and ease of deployment will provide additional fuel consumption. During the forecast period, the cloud-based system category is expected to experience the highest CAGR. Cloud-based systems provide doctors with ability to access medical records from anywhere and at any time. As a result, healthcare providers around the world are now using these devices for image delivery, monitoring, imaging research, and redundant data processing. Working with major market leaders and hospitals and clinics to offer innovative PACS technologies and services can accelerate hospital adoption. Sectra, an international medical imaging IT provider, and ProMedica, a U.S. hospital chain, signed a six-year deal to provide PACS services to ProMedica, for instance, in April 2016.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes NGS-Based RNA Sequencing Market Report 2021-2031

The market is expected to be driven by key factors such as rising cancer prevalence, government funding support in genetic research and technological advancements taking place in the biological research field. In addition, the market is predicted to gain huge traction in the developing countries.

11 May 2021

Read

Visiongain Publishes Single-Use Bioreactors Market Report 2021-2031

Strong product portfolio in the market is one of the major factors accelerating the growth of the market as availability of variants in the single-use systems allows targeted users more options.

11 May 2021

Read

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

Read

Visiongain Publishes Protein Labelling Reagents for Research Use Only (RUO) Market Report 2021-2031

Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.

05 May 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever